Results 21 to 30 of about 2,492,664 (191)

Humoral serological response to the BNT162b2 vaccine is abrogated in lymphoma patients within the first 12 months following treatment with anti-CD2O antibodies

Haematologica, 2021
Patients with lymphoma, especially those treated with anti-CD20 monoclonal antibodies, suffer high COVID-19-associated morbidity and mortality. The goal of this study was to assess the ability of lymphoma patients to generate a sufficient humoral ...
Ronit Gurion, Uri Rozovski, Gilad Itchaki, Anat Gafter-Gvili, Chiya Leibovitch, Pia Raanani, Haim Ben-Zvi, Moran Szwarcwort, Mor Taylor-Abigadol, Eldad J. Dann, Nurit Horesh, Tsofia Inbar, Inna Tzoran, Noa Lavi, Riva Fineman, Shimrit Ringelstein-Harlev, Netanel A. Horowitz   +16 more
doaj   +1 more source

The Role of Monoclonal Antibodies in the Management of Leukemia

Pharmaceuticals, 2010
This article will review the monoclonal antibodies more commonly used in leukemias. In the last three decades, scientists have made considerable progress understanding the structure and the functions of various surface antigens, such as CD20, CD33.
Mohamad Cherry, Aref Al-Kali, Ali Al-Ameri, Alessandra Ferrajoli   +3 more
doaj   +1 more source

Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone

Haematologica, 2012
Background Fc gamma receptor polymorphisms were linked to outcome in follicular lymphoma patients treated with single-agent rituximab, an anti-CD20 monoclonal antibody.
Daniel O. Persky, David Dornan, Bryan H. Goldman, Rita M. Braziel, Richard I. Fisher, Michael LeBlanc, David G. Maloney, Oliver W. Press, Thomas P. Miller, Lisa M. Rimsza   +9 more
doaj   +1 more source

Case Report: Use of Obinutuzumab as an Alternative Monoclonal Anti-CD20 Antibody in a Patient With Refractory Immune Thrombocytopenia Complicated by Rituximab-Induced Serum Sickness and Anti-Rituximab Antibodies

Frontiers in Immunology, 2022
Management of refractory immune thrombocytopenia frequently involves rituximab, a chimeric anti-CD20 monoclonal antibody, to target B cells and induce remission in most patients.
Jennifer R. Blase, David Frame, Thomas F. Michniacki, Kelly Walkovich   +3 more
doaj   +1 more source

Stable expression of a recombinant human antinucleosome antibody to investigate relationships between antibody sequence, binding properties, and pathogenicity [PDF]

, 2005
When purified under rigorous conditions, some murine anti-double-stranded-DNA (anti-dsDNA) antibodies actually bind chromatin rather than dsDNA. This suggests that they may actually be antinucleosome antibodies that only appear to bind dsDNA when they ...
Lambrianides, A, Rahman, A, Anisur Rahman, Isenberg, DA, Mason, LJ, David S Latchman, Lesley J Mason, Manson, JJ, Latchman, DS, Jessica J Manson, David A Isenberg, Joanna D Haley, Haley, JD, Anastasia Lambrianides   +13 more
core   +1 more source

Immunosuppression with Rituximab in Glomerular Diseases in Adults: Who, How and When?

Revista Portuguesa de Nefrologia e Hipertensão, 2023
Rituximab, a monoclonal antibody with the ability to bind itself to CD20, leads to a rapid depletion of B-cells (in around 24-72 hours), limiting antibody formation.
Raquel Pereira Sousa Pinto, Carolina dos Reis Ferreira, André Sotero Araújo Ferreira, Joaquim Manuel Leal Milheiro, Catarina Maia da Veiga, Maria Luísa de Lemos Ferreira Casimiro da Costa, Andreia Raquel Dias da Silva, Carla Maria Pereira Lima, Sérgio José da Silva Lemos   +8 more
doaj   +1 more source

Template-assisted crystallization behavior in stirred solutions of the monoclonal antibody Anti-CD20 : probability distributions of induction times [PDF]

, 2022
We present a method to determine the template crystallization behavior of proteins. This method is a statistical approach that accounts for the stochastic nature of nucleation.
Chen, Wenqian, Heng, Jerry YY, Gerard, Charline J. J., Mastropietro, Teresa F., Rajoub, Nazer, ter Horst, Joop H, Gerard, Charline J. J., Heng, Jerry Y. Y., Gerard, Charline JJ, Briuglia, Maria L, Mastropietro, Teresa F, Briuglia, Maria L., Di Profio, Gianluca, ter Horst, Joop H., Heng Jerry Y Y, Mastropietro Teresa F, ter Horst Joop H, Di Profio Gianluca, Rajoub Nazer, Briuglia Maria L, Gerard Charline J J, Chen Wenqian, Teresa F. Mastropietro, Nazer Rajoub, Gianluca Di Profio, Charline J. J. Gerard, Jerry Y. Y. Heng, Wenqian Chen, Maria L. Briuglia, Joop H. ter Horst   +29 more
core   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

CAQ Corner: Immune‐mediated complications

, 2022
Liver Transplantation, EarlyView.
Mary Thomson, John R. Lake
wiley   +1 more source

Successful treatment of prolonged COVID-19 with Bamlanivimab in a patient with severe B-Cell aplasia due to treatment with an anti-CD20 monoclonal antibody: A case report

Respiratory Medicine Case Reports, 2021
A 71-year-old female patient with B-cell depletion due to treatment with an anti-CD20 monoclonal antibody was admitted for worsening COVID-19. Overall, she had persistent viral shedding, worsening respiratory failure, and progressive pneumonia that did ...
Ayham Daher, Tobias Müller, Jens Spiesshoefer, Michael Dreher, Jens Panse   +4 more
doaj   +1 more source